Tower Research Capital LLC (Trc) Maxcyte, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Maxcyte, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,742 shares of MXCT stock, worth $6,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,742
Previous 39,994
95.64%
Holding current value
$6,549
Previous $187,000
96.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MXCT
# of Institutions
126Shares Held
62MCall Options Held
2.4KPut Options Held
2.1K-
Black Rock Inc. New York, NY7.23MShares$27.2 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY6.56MShares$24.7 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.17MShares$23.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$20.1 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$19 Million6.7% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $382M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...